Orthopedic Surgery Doctors in Boulder, CO Accepting Medicare

26 Orthopedic Surgery doctors found. Showing 21 - 26

Dr. Khemarin R Seng, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730    Fax: 303-449-5821

William M Johnson, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2750 Broadway St, Boulder, CO 80304 Phone: 303-440-3000

Dr. William J Williams, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 933 Alpine Ave, Boulder, CO 80304 Phone: 303-449-2730    Fax: 303-449-9599

Dr. Daniel Lee Master, M.D. Orthopaedic Surgery - Hand Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730    Fax: 303-449-5821

Drigan D Wieder, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730    Fax: 303-449-5821

Dr. Erik Bowman, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730

News Archive

Prior radioprotection via EGLN inhibitor improves survival in mouse model of pancreatic cancer

Administration of the EGLN inhibitor FG-4592 prior to ablative radiotherapy provided protection against fatal gastrointestinal bleeding and improved survival in a mouse model of unresectable pancreatic cancer.

Coffee may protect against a slow growing skin cancer: Study

A new study shows that drinking coffee was associated with decreased risk of a common and slow-growing form of skin cancer called basal cell carcinoma.

MannKind begins MKC1106-MT Phase 2 trial for advanced melanoma

MannKind Corporation today announced the first patient has been dosed in a phase 2 clinical trial of the novel, investigational cancer vaccine MKC1106-MT. As a part of MannKind's cancer immunotherapy program, this phase 2 study will evaluate the safety, tolerability, immune response and clinical response of MKC1106-MT in patients with advanced melanoma.

Researchers use innovative method to screen kinases for cancer drug's effectiveness

In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.

"Zoom Dysmorphia" is driving more people to seek plastic surgery

Patients are seeking plastic surgery in record numbers, citing their appearance on Zoom as a cause. Of particular concern are noses and wrinkles, according to Facial Plastic Surgery & Aesthetic Medicine. Click here to read the article now.

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)